{"nct_id":"NCT01808573","title":"A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting","status":"COMPLETED","status_verified_date":"2021-05","start_date":"2013-03-29","start_date_type":"ACTUAL","primary_completion_date":"2018-09-28","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PBYI"]}